Search filters

List of works by Scott M Schuetze

A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma

scientific article published on 9 June 2015

A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma

scientific article published on 24 November 2020

Adjuvant therapy for soft tissue sarcoma

scientific article published on March 2005

Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options

scientific article published on December 2011

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

scientific article

Chemotherapy in the management of osteosarcoma and Ewing's sarcoma

scientific article published on April 2007

Chordoma: the nonsarcoma primary bone tumor

scientific article

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

scientific article

Complications of a temozolomide overdose: a case report

scientific article

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

scientific article published on 03 January 2020

DR6 as a diagnostic and predictive biomarker in adult sarcoma

scientific article

Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial results

scientific article published on July 2012

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

scientific article

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

scientific article published on 14 September 2015

Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors

scientific article

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules

scientific article

Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.

scientific article

Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors

scientific article

Gastrointestinal stromal tumors, version 2.2014.

scientific article published on June 2014

Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation

scientific article published on April 2008

Histology-Specific Therapy for Advanced Soft Tissue Sarcoma and Benign Connective Tissue Tumors ⬇️

scientific article published on September 1, 2012

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

scientific article

Imaging and response in soft tissue sarcomas

scientific article

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials

scientific article

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors

scientific article

New targets for therapy of sarcoma

scientific article published on July 2008

Next generation sequencing of extraskeletal myxoid chondrosarcoma

scientific article

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

scientific article published on 12 September 2016

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

scientific article published on 4 October 2017

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

scientific article

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

scientific article

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

scientific article published on 18 May 2009

Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas

scientific article

R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study

scientific article

Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

scientific article

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

scientific article

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung

scientific article published on 30 April 2020

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

scientific article published on 20 August 2016

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

scientific article published on 16 July 2013

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

scientific article

Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome

scientific article published on January 2014

Selection of response criteria for clinical trials of sarcoma treatment

scientific article published on January 2008

So-called "inflammatory leiomyosarcoma'': a series of 3 cases providing additional insights into a rare entity

scientific article published on April 2005

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

scientific article

Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines

scientific article

Soft tissue sarcoma, version 2.2014.

scientific article

Targeted therapy for dermatofibrosarcoma protuberans

scientific article published on July 2006

The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004) ⬇️

scientific article published on December 28, 2009

Utility of positron emission tomography in sarcomas

scientific article

[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

scientific article

Paulina is supported by:

About Paulina

Help